{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:20:07Z","timestamp":1785223207004,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Little is known about the changes in disease makers and risk factors in patients with chronic kidney disease (CKD) under nephrological care in Africa. This study aimed to evaluate the baseline level of markers of CKD and their 12-month time-trend in newly referred patients in a tertiary hospital in Cameroon.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective cohort study including 420 patients referred for CKD between 2006 and 2012 to the nephrology unit of the Douala General Hospital in the littoral region of Cameroon. Their disease and risk profile was assessed at baseline and every 3\u00a0months for 1\u00a0year. Estimated glomerular filtration rate (eGFR) was based on MDRD and Schwartz equations. CKD was diagnosed in the presence of eGFR&lt;\u200960\u2009ml\/min\/1.73\u2009m<jats:sup>2<\/jats:sup> and\/or proteinuria&gt;\u20091+ and\/or abnormal renal ultrasound persisting for \u22653\u2009months. Data analysis used mixed linear regressions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 420 patients included, 66.9% were men and mean age was 53.8 (15.1) years. At referral, 37.5% of the participants were at CKD Stage 3, 30.8% at stage 4 and 26.8% at stage 5. There was 168 (40%) diabetic and 319 (75.9%) hypertensive patients. After some improvement during the first 3\u00a0months, eGFR steadily decreased during the first year of follow-up, and this pattern was robust to adjustment for many confounders. Systolic and diastolic blood pressure levels significantly fluctuated during the first twelve months of follow-up. Changes in the levels of other risk factors and markers of disease severity over time were either borderline or non-significant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Patients with CKD in African settings are referred to the nephrologist at advanced stages. This likely translates into a less beneficial effects of specialised care on the course of the disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-020-01760-6","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T12:43:28Z","timestamp":1584535408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Markers and risk factors for chronic kidney disease in sub-Saharan Africans: baseline levels and 12-month trajectories in newly referred patients in Cameroon"],"prefix":"10.1186","volume":"21","author":[{"given":"Halle Marie","family":"Patrice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengne Andre","family":"Pascal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaze Folefack","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djantio","family":"Hilaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doualla Marie","family":"Solange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashuntantang Enow","family":"Gloria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choukem Sim\u00e9on","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"issue":"7","key":"1760_CR1","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O\u2019Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney Disease - a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765.","journal-title":"PLoS One"},{"issue":"9859","key":"1760_CR2","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of Disease study 2010. Lancet. 2012 Dec 15;380(9859):2095\u2013128.","journal-title":"Lancet"},{"issue":"2","key":"1760_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137\u201347.","journal-title":"Ann Intern Med"},{"issue":"11","key":"1760_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A. Kidney Disease: improving global outcomes chronic kidney Disease guideline development work group members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825\u201330.","journal-title":"Ann Intern Med"},{"issue":"8","key":"1760_CR5","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/S0735-1097(03)00163-3","volume":"41","author":"LF Fried","year":"2003","unstructured":"Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am CollCardiol. 2003;41(8):1364\u201372.","journal-title":"J Am CollCardiol"},{"issue":"7","key":"1760_CR6","first-page":"1327","volume":"22","author":"CA Peralta","year":"2011","unstructured":"Peralta CA, Katz R, DeBoer I, Ix J, Sarnak M, Kramer H, et al. Racial and ethnic differences in kidney function decline among persons without chronic kidney disease. J Am SocNephrol. 2011;22(7):1327\u201334.","journal-title":"J Am SocNephrol"},{"issue":"1 Suppl 1","key":"1760_CR7","first-page":"A7, e1","volume":"59","author":"AJ Collins","year":"2012","unstructured":"Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(1 Suppl 1):A7, e1\u2013420.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1760_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000268955","volume":"31","author":"CA Peralta","year":"2010","unstructured":"Peralta CA, Risch N, Lin F, Shlipak MG, Reiner A, Ziv E, et al. The Association of African Ancestry and elevated creatinine in the coronary artery risk development in Young adults (CARDIA) study. Am J Nephrol. 2010;31(3):202\u20138.","journal-title":"Am J Nephrol"},{"issue":"8","key":"1760_CR9","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.2337\/diacare.26.8.2392","volume":"26","author":"BA Young","year":"2003","unstructured":"Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care. 2003;26(8):2392\u20139.","journal-title":"Diabetes Care"},{"issue":"9","key":"1760_CR10","first-page":"1484","volume":"24","author":"MC Foster","year":"2013","unstructured":"Foster MC, Coresh J, Fornage M, Astor BC, Grams M, Franceschini N, et al. APOL1 variants associate with increased risk of CKD among African Americans. J Am SocNephrol. 2013;24(9):1484\u201391.","journal-title":"J Am SocNephrol"},{"issue":"5993","key":"1760_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"G Genovese","year":"2010","unstructured":"Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329(5993):841\u20135.","journal-title":"Science"},{"issue":"7","key":"1760_CR12","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/HJH.0000000000001345","volume":"35","author":"AD Kaze","year":"2017","unstructured":"Kaze AD, Schutte AE, Erqou S, Kengne AP, Echouffo-Tcheugui JB. Prevalence of hypertension in older people in Africa: a systematic review and meta-analysis. J Hypertens. 2017;35(7):1345\u201352.","journal-title":"J Hypertens"},{"issue":"4","key":"1760_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1440-1797.2006.00587.x","volume":"11","author":"I Codreanu","year":"2006","unstructured":"Codreanu I, Perico N, Sharma SK, Schieppati A, Remuzzi G. Prevention programmes of progressive renal disease in developing nations. Nephrology (Carlton). 2006;11(4):321\u20138.","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"1760_CR14","first-page":"1635","volume":"13","author":"BA Kiberd","year":"2002","unstructured":"Kiberd BA, Clase CM. Cumulative risk for developing end-stage renal disease in the US population. J Am SocNephrol. 2002;13(6):1635\u201344.","journal-title":"J Am SocNephrol"},{"issue":"8","key":"1760_CR15","first-page":"1361","volume":"21","author":"TP Alves","year":"2010","unstructured":"Alves TP, Wang X, Wright JT, Appel LJ, Greene T, Norris K, et al. Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. J Am SocNephrol. 2010;21(8):1361\u20139.","journal-title":"J Am SocNephrol"},{"issue":"2","key":"1760_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/j.ajkd.2013.01.012","volume":"62","author":"CA Peralta","year":"2013","unstructured":"Peralta CA, Vittinghoff E, Bansal N, Jacobs D, Muntner P, Kestenbaum B, et al. Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the coronary artery risk development in Young adults (CARDIA) study. Am J Kidney Dis. 2013;62(2):261\u20136.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"1760_CR17","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1016\/S2214-109X(16)00071-1","volume":"4","author":"B Ene-Iordache","year":"2016","unstructured":"Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307\u201319.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"1760_CR18","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1016\/S2214-109X(14)70002-6","volume":"2","author":"JW Stanifer","year":"2014","unstructured":"Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(3):e174\u201381.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"1760_CR19","first-page":"232","volume":"6","author":"EK Sumaili","year":"2010","unstructured":"Sumaili EK, Krzesinski J-M, Cohen EP, Nseka NM. Epidemiology of chronic kidney disease in the Democratic Republic of Congo: review of cross-sectional studies from Kinshasa, the capital. NephrolTher. 2010;6(4):232\u20139.","journal-title":"NephrolTher"},{"issue":"6","key":"1760_CR20","doi-asserted-by":"publisher","first-page":"e004747","DOI":"10.1136\/bmjopen-2013-004747","volume":"4","author":"M Werfalli","year":"2014","unstructured":"Werfalli M, Musekiwa A, Engel ME, Ross I, Kengne AP, Levitt NS. The prevalence of type 2 diabetes mellitus among older people in Africa: a systematic review study protocol. BMJ Open. 2014;4(6):e004747.","journal-title":"BMJ Open"},{"issue":"1 Suppl 1","key":"1760_CR21","first-page":"S1\u201313","volume":"19","author":"S Naicker","year":"2009","unstructured":"Naicker S. End-stage renal disease in sub-Saharan Africa. Ethn Dis. 2009;19(1 Suppl 1):S1\u201313\u20135.","journal-title":"Ethn Dis"},{"key":"1760_CR22","first-page":"14","volume":"1","author":"MP Halle","year":"2013","unstructured":"Halle MP, Luma H, Temfack E, Vanessa T, Kaze F, Ashuntantang G, et al. Prevalence of hepatitis B surface antigen and anti-HIV antibodies among patients on maintenance haemodialysis in Douala, Cameroon. Health Sci Dis. 2013 Sep;1:14.","journal-title":"Health Sci Dis"},{"key":"#cr-split#-1760_CR23.1","doi-asserted-by":"crossref","unstructured":"Halle MP, Takongue C, Kengne AP, Kaze FF, Ngu KB. Epidemiological profile of patients with end stage renal disease in a referral hospital in Cameroon. BMC Nephrology [Internet]. 2015;16","DOI":"10.1186\/s12882-015-0044-2"},{"key":"#cr-split#-1760_CR23.2","unstructured":"(1) Available from: http:\/\/www.biomedcentral.com\/1471-2369\/16\/59, [cited 2015 Dec 24]."},{"issue":"5","key":"1760_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/08860220902882014","volume":"31","author":"MP Halle","year":"2009","unstructured":"Halle MP, Kengne AP, Ashuntantang G. Referral of patients with kidney impairment for specialist care in a developing country of sub-Saharan Africa. Ren Fail. 2009;31(5):341\u20138.","journal-title":"Ren Fail"},{"key":"1760_CR25","unstructured":"Halle MP, Tsinga L, Fottsoh AF, Kaze FF, Sone AM, Ashuntantang G. Does Timing of Nephrology Referral Influence Outcome among Patients on Maintenance Hemodialysis in Cameroon? Health Sci Dis [Internet]. 2017;18(3) Available from: http:\/\/www.hsd-fmsb.org\/index.php\/hsd\/article\/view\/862."},{"issue":"9981","key":"1760_CR26","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet [Internet]. 2015;385(9981):1975\u201382 Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673614616019, [cited 2016 Apr 26].","journal-title":"Lancet [Internet]"},{"issue":"1","key":"1760_CR27","first-page":"230","volume":"20","author":"MP Halle","year":"2017","unstructured":"Halle MP, Jimkap NN, Kaze FF, Fouda H, Belley EP. Ashuntantang G. Cost of care for patients on maintenance haemodialysis in public facilities in Cameroon. Afr J Nephrol [Internet]. 2017;20(1):230\u20137 Available from: http:\/\/www.journals.ac.za\/index.php\/ajn\/article\/view\/2548, [cited 2018 Jan 24].","journal-title":"Afr J Nephrol [Internet]"},{"issue":"4","key":"1760_CR28","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1016\/S2214-109X(17)30057-8","volume":"5","author":"G Ashuntantang","year":"2017","unstructured":"Ashuntantang G, Osafo C, Olowu WA, Arogundade F, Niang A, Porter J, et al. Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review. Lancet Global Health [Internet]. 2017;5(4):e408\u201317 Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214109X17300578, [cited 2017 Oct 31].","journal-title":"Lancet Global Health [Internet]"},{"issue":"1","key":"1760_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12882-016-0377-5","volume":"17","author":"MP Halle","year":"2016","unstructured":"Halle MP, Ashuntantang G, Kaze FF, Takongue C, Kengne A-P. Fatal outcomes among patients on maintenance haemodialysis in sub-Saharan Africa: a 10-year audit from the Douala general Hospital in Cameroon. BMC Nephrol. 2016;17(1):165.","journal-title":"BMC Nephrol"},{"issue":"4","key":"1760_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247\u201354.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1760_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","volume":"34","author":"GJ Schwartz","year":"1987","unstructured":"Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. PediatrClin North Am. 1987;34(3):571\u201390.","journal-title":"PediatrClin North Am"},{"key":"1760_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"K Disease","year":"2013","unstructured":"Disease K. Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"1760_CR33","doi-asserted-by":"publisher","first-page":"F863","DOI":"10.1152\/ajprenal.00068.2004","volume":"289","author":"KV Lemley","year":"2005","unstructured":"Lemley KV, Boothroyd DB, Blouch KL, Nelson RG, Jones LI, Olshen RA, et al. Modeling GFR trajectories in diabetic nephropathy. Am J Physiol Renal Physiol. 2005 Oct;289(4):F863\u201370.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"1760_CR34","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1053\/j.ajkd.2011.11.044","volume":"59","author":"AM O\u2019Hare","year":"2012","unstructured":"O\u2019Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, et al. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis. 2012;59(4):513\u201322.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1760_CR35","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1053\/j.ajkd.2011.12.009","volume":"59","author":"L Li","year":"2012","unstructured":"Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, et al. Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis. 2012;59(4):504\u201312.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"1760_CR36","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/ndt\/gfu320","volume":"30","author":"K Leffondre","year":"2015","unstructured":"Leffondre K, Boucquemont J, Tripepi G, Stel VS, Heinze G, Dunkler D. Analysis of risk factors associated with renal function trajectory over time: a comparison of different statistical approaches. Nephrol Dial Transplant. 2015;30(8):1237\u201343.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1760_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.ajkd.2016.02.039","volume":"68","author":"Y Xie","year":"2016","unstructured":"Xie Y, Bowe B, Xian H, Balasubramanian S, Al-Aly Z. Estimated GFR trajectories of people entering CKD stage 4 and subsequent kidney Disease outcomes and mortality. Am J Kidney Dis. 2016;68(2):219\u201328.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1760_CR38","first-page":"273","volume":"36","author":"D Collister","year":"2016","unstructured":"Collister D, Ferguson T, Komenda P, Tangri N. The patterns, risk factors, and prediction of progression in chronic kidney Disease: a narrative review. SeminNephrol. 2016;36(4):273\u201382.","journal-title":"SeminNephrol"},{"issue":"4","key":"1760_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1053\/j.ajkd.2008.06.023","volume":"52","author":"A Levin","year":"2008","unstructured":"Levin A, Djurdjev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis. 2008;52(4):661\u201371.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"1760_CR40","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1056\/NEJMoa0910975","volume":"363","author":"LJ Appel","year":"2010","unstructured":"Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010;363(10):918\u201329.","journal-title":"N Engl J Med"},{"issue":"2","key":"1760_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1053\/j.ajkd.2016.02.046","volume":"68","author":"BA Young","year":"2016","unstructured":"Young BA, Katz R, Boulware LE, Kestenbaum B, de Boer IH, Wang W, et al. Risk factors for rapid kidney function decline among African Americans: the Jackson heart study (JHS). Am J Kidney Dis. 2016;68(2):229\u201339.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1760_CR42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/j.ajkd.2008.04.026","volume":"52","author":"ES Johnson","year":"2008","unstructured":"Johnson ES, Thorp ML, Platt RW, Smith DH. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis. 2008;52(4):653\u201360.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1760_CR43","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archinte.164.6.659","volume":"164","author":"DS Keith","year":"2004","unstructured":"Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659\u201363.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1760_CR44","first-page":"1444","volume":"17","author":"A Ishani","year":"2006","unstructured":"Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am SocNephrol. 2006;17(5):1444\u201352.","journal-title":"J Am SocNephrol"},{"issue":"4","key":"1760_CR45","first-page":"1299","volume":"18","author":"JL Xue","year":"2007","unstructured":"Xue JL, Eggers PW, Agodoa LY, Foley RN, Collins AJ. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am SocNephrol. 2007;18(4):1299\u2013306.","journal-title":"J Am SocNephrol"},{"issue":"3","key":"1760_CR46","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ki.1996.111","volume":"49","author":"K Iseki","year":"1996","unstructured":"Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 1996;49(3):800\u20135.","journal-title":"Kidney Int"},{"issue":"3","key":"1760_CR47","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1053\/j.ajkd.2014.07.026","volume":"65","author":"ME Grams","year":"2015","unstructured":"Grams ME, Li L, Greene TH, Tin A, Sang Y, Kao WHL, et al. Estimating time to ESRD using kidney failure risk equations: results from the African American study of kidney Disease and hypertension (AASK). Am J Kidney Dis. 2015;65(3):394\u2013402.","journal-title":"Am J Kidney Dis"},{"issue":"24","key":"1760_CR48","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2011.861","volume":"305","author":"IH de Boer","year":"2011","unstructured":"de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305(24):2532\u20139.","journal-title":"JAMA"},{"issue":"3","key":"1760_CR49","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/ndt\/gfp534","volume":"25","author":"R Hanratty","year":"2010","unstructured":"Hanratty R, Chonchol M, Miriam Dickinson L, Beaty BL, Estacio RO, MacKenzie TD, et al. Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrol Dial Transplant [Internet]. 2010;25(3):801\u20137 Available from: https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gfp534, [cited 2018 Dec 6].","journal-title":"Nephrol Dial Transplant [Internet]"},{"issue":"6","key":"1760_CR50","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ki.1984.229","volume":"26","author":"RD Lindeman","year":"1984","unstructured":"Lindeman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int. 1984;26(6):861\u20138.","journal-title":"Kidney Int"},{"issue":"3","key":"1760_CR51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1291\/hypres.31.433","volume":"31","author":"E Imai","year":"2008","unstructured":"Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, et al. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res. 2008;31(3):433\u201341.","journal-title":"Hypertens Res"},{"issue":"12","key":"1760_CR52","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/sj.ki.5000270","volume":"69","author":"BR Hemmelgarn","year":"2006","unstructured":"Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, et al. Progression of kidney dysfunction in the community dwelling elderly. Kidney Int. 2006;69(12):2155\u201361.","journal-title":"Kidney Int"},{"issue":"12","key":"1760_CR53","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851\u201360.","journal-title":"N Engl J Med"},{"issue":"7","key":"1760_CR54","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/sj.ki.5001657","volume":"70","author":"F Zannad","year":"2006","unstructured":"Zannad F, Kessler M, Lehert P, Gr\u00fcnfeld JP, Thuilliez C, Leizorovicz A, et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int. 2006;70(7):1318\u201324.","journal-title":"Kidney Int"},{"issue":"4","key":"1760_CR55","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1046\/j.1523-1755.2003.00885.x","volume":"63","author":"WF Keane","year":"2003","unstructured":"Keane WF, Brenner BM, de Zeeuw D, Grunfeld J-P, McGill J, Mitch WE, et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int. 2003;63(4):1499\u2013507.","journal-title":"Kidney Int"},{"issue":"12","key":"1760_CR56","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861\u20139.","journal-title":"N Engl J Med"},{"issue":"13","key":"1760_CR57","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/archinte.163.13.1555","volume":"163","author":"GL Bakris","year":"2003","unstructured":"Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med. 2003;163(13):1555\u201365.","journal-title":"Arch Intern Med"},{"issue":"9","key":"1760_CR58","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/ajh\/hpv003","volume":"28","author":"A Hirayama","year":"2015","unstructured":"Hirayama A, Konta T, Kamei K, Suzuki K, Ichikawa K, Fujimoto S, et al. Blood pressure, proteinuria, and renal function decline: associations in a large community-based population. Am J Hypertens. 2015;28(9):1150\u20136.","journal-title":"Am J Hypertens"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01760-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-020-01760-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01760-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:17:20Z","timestamp":1616026640000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01760-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1760"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01760-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the ethical committee board of the Douala University and administrative authorization from the DGH. Consent to participate wasn\u2019t required since this study was based on available health records, with no further contact with participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}